Illumina and PacBio Sequencing of Human and Mouse DNA and RNA
Location: Ontario, Canada
Actions
Paste your website. We'll send matching US & Canadian bids every morning.
Documents (3)
Downloads need a free Narwin account.
- 1000273702_complete-rfp-(final-(en-(amendmen-1.pdfPDF · 800.9 KB
- 1000273702_bidder-q-a-1.pdfPDF · 247.2 KB
- 1000273702_complete-rfp-(final(en.pdfPDF · 801.6 KB
Have an account? Sign in
Description
Read full description
The Mechanistic Studies Division (MSD) of Health Canada’s Environmental Health Research and Science Bureau investigates the pathways by which physical, chemical and microbiological agents can cause adverse health effects. To determine how chemical substances cause DNA damage that can lead to illnesses like cancer or inherited diseases, MSD requires high-throughput genome sequencing services utilizing Illumina and Pacific Biosciences (PacBio) platforms. The primary objective of this contract is to secure long-term high-quality sequencing services for pre-prepared DNA libraries and genomic DNA and/or RNA utilizing Illumina or PacBio Revio platforms for the full duration of projects funded until up to 2030-2031. This requirement encompasses the sequencing of multiple mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA and/or RNA samples in direct support of four distinct research projects. These projects are distributed across the Division and funded through three separate programs. Collectively, they employ advanced genomic technologies to support public health protection by identifying environmental mutagens, evaluating occupational hazards, and improving toxicological testing methodologies. Specifically, this work will use ecNGS, whole-genome sequencing (WGS), whole-exome sequencing and/or RNA-sequencing approaches to detect and characterize both spontaneous mutations and mutations induced by chemical and environmental exposures in mouse and human DNA as well as gene expression changes. The resulting data will contribute to a better understanding of mutagenic mechanisms, exposure-related genetic damage, and the development of more sensitive and informative approaches for genetic toxicology and human health risk assessment.
Additional Information
Source
canadabuys
Status
open
Procurement Method
Competitive - Open bidding
Procurement Category
Services
Selection Criteria
Lowest Price
Regions of Opportunity
National Capital Region (NCR)
Regions of Delivery
Chile *South Korea *United States of America *Peru *Honduras *Europe *Canada *Colombia *Panama
Reference Number
cb-321-95217286
Amendment Number
001
Contracting Entity
Department of Health (HC)
Contact Name
Wesley Phillips
Contact Email
Contact Country
Canada
Organization City
Ottawa
Organization Province / State
Ontario
Organization Country
Canada
Last Updated
November 17, 2026
Frequently Asked Questions
When is the proposal submission deadline?
The proposal submission deadline is December 10, 2026 (21 days left).
Where can I submit a proposal or get solicitation documents?
You can access the full solicitation documents and submit your proposal at the official source:
Visit Official SourceOpen bids from this agency
- Installation of Charging Stations for Electric Vehicles
Competitive - Open bidding · Due December 11, 2026
- DTB Security Services
Competitive - Selective tendering · Due December 1, 2026
- Illumina and PacBio Sequencing of Human and Mouse DNA and RNA
Competitive - Open bidding · Due December 3, 2026
Get new bids from this agency by email
Follow for freeExplore More Opportunities
Narwin checks SAM.gov, CanadaBuys, BC Bid and 50+ city portals daily and emails you only the bids that fit your business. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.